GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Related Posts
GlycoMantra is one of the featured companies that the Maryland Department of Commerce is showcasing…
GlycoMantra has been awarded a two-year SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted…